Aligos Therapeutics will present multiple posters at AASLD

SOUTH SAN FRANCISCO, Calif., Nov. 7, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”) is a clinical-stage biopharmaceutical company focused on developing novel therapies to Addressing Unmet Medical Needs and Viral Diseases in the Liver, today announced that the company will present six … Read more

INADI establishes the National Observatory on Stigma and Discrimination against HIV, Viral Hepatitis, Other Sexually Transmitted Infections and Tuberculosis within the framework of Law No. 27,675

Creation of National Observatory on HIV, Viral Hepatitis, Other Sexually Transmitted Infections and Tuberculosis Stigma and Discrimination The agency will operate under the jurisdiction of the Directorate of Anti-Discrimination Policy and Practice of the National Institute against Discrimination, Xenophobia and Racism. The Observatory was established … Read more

A square peg in a round hole: Treating hepatitis C

Abstract A range of barriers to care reduce access to hepatitis C treatment. We recommend investments in patient-centered care strategies to initiate and engage these vulnerable populations in treatment, such as community-based educational peer support groups. Barriers to implementing these patient-centered care strategies remain. Am … Read more